Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 2
Bayer Lists Stock on New York Exchange Amid Marked Increase in Reported Baycol Deaths, Management Shake-Up
The Warnings Page: Ephedra Recall in Canada; FDA Investigates Kava; Bristol-Myers, Novartis Issue Warnings
Plaintiffs Argue That Injunctive Relief in Vioxx/Celebrex Suit Not Preempted by FDA Regulation
Plaintiffs File Suit Against Bayer Seeking Class Certification and Medical Monitoring Fund
Plaintiffs Seek to Delete Class Action Allegations and Pursue Individual Claims
Class Action Certification Discovery Schedule Set in Propulsid MDL
Three-Phase Medical Monitoring Class Action Trial Proposed in Propulsid MDL
Gulf War Vet Claims Injuries Are Related to Thimerosal-Containing Vaccines
